Reproductive Genetic Innovations (RGI) is an internationally recognized leader in assisted reproductive technologies, performing advanced Preimplantation Genetic Testing (PGT). PGT, in conjunction with an In Vitro Fertilization (IVF) cycle, is the only way to determine if an embryo contains abnormalities or the normal number of chromosomes, reducing the chance of failed implantation or an early miscarriage, and/or identifying whether an embryo is predicted to be affected with a specific genetic condition prior to achieving pregnancy.